The Company’s improved, new Vitastem products have recently begun large scale production...
Revenues increased by over 4000% in 2021, while liabilities decreased by more than 25%...
LOS ANGELES, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) published a Quarterly Report for the three months ended March 31, 2021, on the OTC Markets website reporting...
The Company has finalized a ten-year $12 million licensing agreement with a Dubai Company
Dr. Chris Otiko will be traveling to Dubai this month to finalize a 10-year, $12 million contract
LOS ANGELES, May 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announced they are nearing the end of their discussions with a major healthcare network to finalize an...
The Company realized significant Q1 revenue growth due to increased online retail sales and proceeds from a licensing agreement
The Company expects to completely self-fund all operations going forward
LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announces the completion of a licensing agreement with a group of affiliated wound care medical practices....
LOS ANGELES, Jan. 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), President and CEO, Dr. Christopher Otiko offers a review of 2020 and provides a summary of his expectations...